5-AMINO-1MQ + NAD+ is a complementary peptide research combination that pairs a selective NNMT inhibitor with nicotinamide adenine dinucleotide precursor activity. This formulation supports in-vitro investigation of NAD+-dependent metabolic pathways and enzymatic systems in controlled laboratory environments.

Supplied as capsules for convenient handling and dosing, this product is intended exclusively for controlled laboratory research by qualified professionals.

Chemical Information:

• 5-AMINO-1MQ: Selective NNMT inhibitor, C10H11N2+ salt, MW 159.21
• NAD+: Nicotinamide adenine dinucleotide, C21H27N7O14P2, MW 663.43
• Combined Formulation: Dual-activity research peptide blend
• Compound Class: Metabolic pathway modulator combination

Research Applications:

• In-vitro co-evaluation of NNMT inhibition and NAD+ availability in enzymatic assays
• Investigation of NAD+-dependent enzymatic activity in cell culture systems
• Study of metabolic pathway interactions in laboratory settings
• Examination of redox balance and metabolic enzyme function in controlled experiments

Storage and Handling:

• Store at 2-8°C in a cool, dry environment away from direct light
• Keep container tightly sealed; protect from moisture
• Handle with appropriate laboratory safety protocols
• Maintain sterile technique when opening or handling capsules

Product Specifications:

• Purity: ≥99% (HPLC, each component)
• Appearance: Capsules with consistent fill
• Form: Vegetarian capsules
• Quantity: 60 capsules (5mg 5-AMINO-1MQ + 5mg NAD+ per capsule)

Compliance Notice:
FOR RESEARCH USE ONLY — Not for human or veterinary consumption. This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the Food and Drug Administration for any purpose.